Related Experiment Video
Updated: Apr 24, 2026

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Molecular imprinting for neurology: Materials, applications, and limitations
Xiaohan Ma1, Yingqi Ma1, Claudia Marino2
1Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute Royal Free Hospital, UCL Medical School London UK.
Molecularly imprinted polymers (MIPs) offer a robust synthetic alternative to biological agents for neurological applications, showing promise in diagnostics and therapeutics. Challenges in clinical translation remain, but ongoing research addresses these limitations for future neurological tools.
Area of Science:
- Materials Science and Neuroscience
- Biomaterials Engineering
Background:
- Neurological disorders necessitate advanced diagnostic and therapeutic tools.
- Conventional biological agents face limitations in stability, brain penetration, and cost.
- Molecularly imprinted polymers (MIPs) present a customizable and robust synthetic alternative.
Purpose of the Study:
- To review the application of MIPs in neurology, covering diagnostics, research, and therapy.
- To detail MIP formats, preparation, characterization, and their advantages/limitations.
- To discuss challenges and emerging strategies for clinical translation of MIPs in neurology.
Main Methods:
- Overview of MIP formats used in neurological applications.
- Exploration of MIP applications in nerve agent detection, neurotransmitter/biomarker analysis, and drug development/delivery.
- Discussion of challenges like biodegradability and biocompatibility, and potential solutions.
Main Results:
- MIPs demonstrate high thermal/chemical stability, reusability, and design flexibility.
- Key application areas include detection of nerve agents, neurotransmitters, and biomarkers.
- MIPs show potential in drug development, delivery, and direct biological activity for neurological conditions.
Conclusions:
- MIPs offer significant advantages over biological agents for neurological tools.
- Clinical translation is hindered by biodegradability and biocompatibility concerns.
- Emerging strategies are being developed to overcome these barriers for wider MIP adoption in neurology.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Imprinting
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

